Back to top
more

AdvisorShares Pure Cannabis ETF: (YOLO)

(Delayed Data from NYSE) As of Jul 17, 2024 03:33 PM ET

$3.50 USD

3.5
26,406

-0.05 (-1.41%)

Volume: 26,406

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $3.50 0.00 (0.00 %) 5:32 PM ET

Zacks News

Sanghamitra Saha headshot

Cannabis ETF (YOLO) Hits New 52-Week High

This cannabis ETF hits a new 52-week high. Are more gains in store for this ETF?

Neena Mishra headshot

Why Cannabis Stocks & ETFs Are Soaring

Marijuana stocks are rising on hopes of favorable regulatory environment

Sweta Killa headshot

Cannabis ETFs Hot Ahead of Elections: Here's Why?

With the election just a day away, five states are seeking to legalize marijuana through ballot measures.

Sweta Jaiswal, FRM headshot

Cannabis ETFs Surge on Kamala Harris' Decriminalizing Marijuana Pledge

Democratic vice-presidential nominee Kamala Harris buoys investors' optimism on the marijuana industry by commenting favorably on the space during a debate with her Republican counterpart Mike Pence.

Sanghamitra Saha headshot

Top ETF Stories of Coronavirus-Induced Q2

These ETF events ruled the broader market in the second quarter.

    Sanghamitra Saha headshot

    Top ETF Stories of May

    The ETF headlines in May were ruled by the reopening of economies, hopes for a COVID-19 vaccine and global economic stimulus.

      Sanghamitra Saha headshot

      4 ETF Areas Up At Least 20% in May

      These ETF areas skyrocketed in May and easily beat the broader market.

      Sanghamitra Saha headshot

      How Cannabis ETFs Beat S&P 500 Past Month

      Cannabis stocks and ETFs jumped last week. Here's why.

      Sanghamitra Saha headshot

      Are Marijuana Stocks, ETFs Poised for Upbeat Earnings?

      "Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.

      Sanghamitra Saha headshot

      Are Marijuana Stocks & ETFs Coronavirus-Proof?

      Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?

      Sanghamitra Saha headshot

      What Do Canopy Earnings Say About Cannabis ETFs?

      Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?

      Sweta Killa headshot

      Cannabis ETFs Are Soaring in 2020: Will the Trend Continue?

      With a greater legislative push to legalize recreational marijuana, cannabis ETFs are soaring to start the year and are likely to continue doing so.

      Sanghamitra Saha headshot

      What's Ahead for Marijuana ETFs After a Dismal Show in 2019?

      Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.

      Sanghamitra Saha headshot

      Best & Worst ETF Areas of Last Week

      Inside the ETF gainers and losers of last week.

      Sweta Killa headshot

      Cannabis ETFs in Focus on Thanksgiving Weekend

      Cannabis spending rises over the Thanksgiving holiday period, especially Green Wednesday as well as on Black Friday.

      Sanghamitra Saha headshot

      Marijuana ETFs Bounce Back: Can the Rally Last?

      Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.

      Sanghamitra Saha headshot

      Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?

      A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.

      Sanghamitra Saha headshot

      Top ETF Stories of October

      Announcement of phase-one trade deal, Fed rate cut, moderate earnings, marijuana crash and Brexit extension regulated the ETF world in October.

      Sanghamitra Saha headshot

      Should You Buy the Dip in Marijuana ETFs Ahead of Earnings?

      Hexo's downbeat results weigh on marijuana space but many key pot companies are likely to beat in November. This could provide a good entry points to pot ETFs.

      Sanghamitra Saha headshot

      Top and Flop ETFs of October

      Signs of some progress in the U.S.-China trade relation, Brexit doldrums, oil price rally and mixed earnings pulled the stings of the market movement and made these ETFs winners and losers.

      Sanghamitra Saha headshot

      One More Marijuana ETF on the Block

      As Global X launches a fresh pot ETF, let's explore the product in detail.

      Neena Mishra headshot

      Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF

      CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.

      Neena Mishra headshot

      Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF

      CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.

      Sanghamitra Saha headshot

      ETFs in Focus as Consolidation Drives Marijuana Industry

      Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.

      Neena Mishra headshot

      Marijuana & Blockchain ETFs: Should You Buy?

      Cannabis and blockchain are high-risk, high-reward areas of the market. Should investors consider these ETFs?